Skip to main content
Linde India Limited logo

Linde India Limited — Investor Relations & Filings

Ticker · LINDEINDIA ISIN · INE473A01011 LEI · 549300I8YN6PVG2KEU64 BSE.NS Manufacturing
Filings indexed 682 across all filing types
Latest filing 2024-11-15 Regulatory Filings
Country IN India
Listing BSE.NS LINDEINDIA

About Linde India Limited

https://www.linde.in/

Linde India Limited specializes in the production and distribution of industrial, medical, and specialty gases. The company operates through two primary business segments: Gases and Engineering. The Gases segment provides a comprehensive portfolio including oxygen, nitrogen, argon, hydrogen, and various specialty gas mixtures tailored for diverse applications. The Engineering segment focuses on the design, manufacture, and installation of air separation units, cryogenic plants, and gas processing facilities. Serving sectors such as healthcare, steel, chemicals, and electronics, the company leverages advanced gas application technologies and an extensive distribution network. Its operations are characterized by a commitment to safety, operational excellence, and the delivery of high-purity gas solutions to meet complex industrial requirements.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings
2024-11-15 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document contains a letter addressed to stock exchanges (BSE and NSE) regarding the publication of an extract of consolidated financial results for the quarter and half year ended 30 September 2024. It mentions that these results were approved by the Board of Directors on 7 November 2024 and have been published in newspapers as per SEBI regulations. The document is essentially an announcement of the publication of financial results extracts, not the full financial report itself. Additionally, the document includes a public notice under Section 13(2) of the SARFAESI Act related to loan defaults and asset possession, which is a regulatory announcement but unrelated to financial reporting. The primary focus is the announcement of the extract of financial results publication, which is a Regulatory Filing (RNS) rather than a full Earnings Release (ER) or Interim Report (IR). The document length is 15,000 characters, but the content is mainly an announcement and public notices, not detailed financial statements or analysis. Therefore, the appropriate classification is Regulatory Filings (RNS).
2024-11-09 English
Financial Result Updates
Regulatory Filings
2024-11-07 English
Outcome of Board Meeting
Regulatory Filings
2024-11-07 English
Loss of Share Certificates
Regulatory Filings
2024-11-06 English
Issue of Duplicate Share Certificate
Regulatory Filings
2024-11-05 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.